Related Experiment Video
Updated: Jun 25, 2026
09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Hypersensitivity pneumonitis.
M Girard1, Y Lacasse, Y Cormier
1Centre de recherche, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Québec, QC, Canada.
Allergy
|February 13, 2009
Summary
Hypersensitivity pneumonitis (HP) is an immune response to inhaled antigens causing lung damage. Early diagnosis and antigen avoidance are crucial, as treatments remain limited, with corticosteroids being the primary option.
Area of Science:
- Pulmonology
- Immunology
- Environmental Medicine
Background:
- Hypersensitivity pneumonitis (HP) is an immune-mediated lung disease triggered by inhaled antigens, first described in farmers exposed to moldy hay.
- It can manifest as acute, infection-like symptoms or lead to progressive, irreversible lung damage, including fibrosis and emphysema.
Purpose of the Study:
- To summarize the current understanding of hypersensitivity pneumonitis, including its causes, immune mechanisms, diagnosis, and treatment.
- To highlight the challenges in managing HP and its potential for severe, life-threatening outcomes.
Main Methods:
- Review of historical cases and evolution of understanding regarding HP.
- Analysis of current diagnostic criteria and insights into the complex immune pathways involved.
- Evaluation of established and emerging treatment strategies for HP.
Main Results:
- HP arises from an exaggerated immune response to diverse environmental antigens.
- Immune mechanisms involve pro-inflammatory cytokines and dysregulation of immune control cells like surfactant, dendritic, and T-regulatory cells.
- Despite improved understanding, treatment options remain limited, with oral corticosteroids and antigen avoidance being key.
Conclusions:
- Hypersensitivity pneumonitis requires prompt diagnosis and management to prevent irreversible lung damage.
- Further research into the immune mechanisms of HP is needed to develop more effective targeted therapies.
- Antigen avoidance and corticosteroids are the current mainstays of HP management, with significant implications for patient prognosis.
Related Concept Videos
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...